Financial

News

GSK names Burberry's Julie Brown as its new CFO

GSK has said that its chief financial officer Iain Mackay will stand down from the role in May next year, to be replaced by Julie Brown, currently chief operating and financial officer at l

News

Novartis probed by Swiss authorities over 'unlawful' patent ...

The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a "possible u

News

Merck takeover talks with Seagen have hit a hurdle; report

Merck & Co's negotiations with Seagen over a possible takeover have stalled because the two sides cannot agree on a price, according to Bloomberg, citing people familiar with the matter

News

Novartis decides Sandoz' future – and it's a spin-out

After months of deliberation, and no formal offers from a buyer, Novartis has decided that its generics business Sandoz will be spun out into an independent company.

News

Mereo fights revolt by largest shareholder Rubric

UK biotech Mereo BioPharma is attempting to face down a revolt by Rubric Capital Management – its largest shareholder holding around 14% of the company – which is agitating for changes to i

News

AstraZeneca raises 2022 guidance, names Demaré as non-exec c...

AstraZeneca chief executive Pascal Soriot said this morning that strong revenue increases in 2022 – fuelled by its COVID-19 antibody Evusheld and oncology drugs – have allowed the company t

GSK names Burberry's Julie Brown as its new CFO

Novartis probed by Swiss authorities over 'unlawful' patent ...

Merck takeover talks with Seagen have hit a hurdle; report

Novartis decides Sandoz' future – and it's a spin-out

Mereo fights revolt by largest shareholder Rubric

AstraZeneca raises 2022 guidance, names Demaré as non-exec c...

Threat of Trump's pharma tariffs looms again

Using AI-driven synthetic personas to take your insights fur...

Financial

Editor's Picks